Tower Research Capital LLC (Trc) Treace Medical Concepts, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,856 shares of TMCI stock, worth $33,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,856
Previous 243
2309.88%
Holding current value
$33,964
Previous $3,000
1166.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TMCI
# of Institutions
129Shares Held
39.5MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$31.1 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$23.6 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$21.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$21 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.83MShares$16.4 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $321M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...